Detection of cancer through exhaled breath: A systematic review

Oncotarget

Volumn 6, Issue 36, 2015, Pages 38643-38657

  Krilaviciute, Agne ^a   Heiss, Jonathan Alexander ^a   Leja, Marcis ^b   Kupcinskas, Juozas ^c   Haick, Hossam ^d   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF LATVIA   (Latvia)

^c LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Breath analysis; Cancer detection; Systematic review; VOC; Volatile organic compound

Indexed keywords

2 BUTANONE; 2,6,11 TRIMETHYLDODECANE; 3 HYDROXYBUTAN 2 ONE; 3 METHYLHEXANE; 5 (2 METHYLPROPYL)NONANE; 8 HEXYLPENTADECANE; ALPHA METHYLSTYRENE; BENZALDEHYDE; BUTAN 1 OL; BUTYLCRESOL; CARYOPHYLLENE; DEC 1 ENE; DECANE; DODECANE; ETHENYLBENZENE; HEPTANAL; HEXADECANAL; HEXANAL; NAPHTHALENE; NONANAL; OCTANAL; PROPANOL; TRICHLOROETHYLENE; UNCLASSIFIED DRUG; VOLATILE AGENT; TUMOR MARKER;

AREA UNDER THE CURVE; BREAST CANCER; BREATH ANALYSIS; CANCER DIAGNOSIS; COLORECTAL CANCER; DESORPTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRONIC NOSE; EXPIRED AIR; FEMALE GENITAL TRACT CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; ION MOBILITY SPECTROMETRY; LIVER CANCER; LUNG CANCER; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MESOTHELIOMA; MULTI CAPILLARY COLUMN ION MOBILITY SPECTROMETRY; OVARY CANCER; PROSTATE CANCER; PROTON TRANSFER REACTION MASS SPECTROMETRY; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SELECTED ION FLOW TUBE MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY; SOLID PHASE MICROEXTRACTION; STOMACH CANCER; SYSTEMATIC REVIEW; THERMAL DESORPTION; THYROID CANCER; EXHALATION; LUNG NEOPLASMS; PROCEDURES;

BIOMARKERS, TUMOR; BREATH TESTS; EXHALATION; HUMANS; LUNG NEOPLASMS;

EID: 84948808339     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5938     Document Type: Review

References (108)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global Cancer Statistics. Ca: a Cancer Journal for Clinicians. 2011; 61:69-90.
2. Ferlay JI, Soerjomataram M, Ervik R, Dikshit S, Eser C, Mathers M, Rebelo DM, Parkin FD and Bray F. (2013). GLOBOCAN 2012 v10, Cancer Incidence and Mortality Worldwide: IARC CancerBase No 11. (Lyon, France: International Agency for Research on Cancer ).
3. Horvath I and de Jongste JE. (2010). Exhaled Biomarkers: European Respiratory Society).
4. Amann A, Mochalski P, Ruzsanyi V, Broza YY and Haick H. Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties. Journal of breath research. 2014; 8:016003.
5. Haick H, Broza YY, Mochalski P, Ruzsanyi V and Amann A. Assessment, origin, and implementation of breath volatile cancer markers. Chemical Society reviews. 2014; 43:1423-1449.
6. (1993). IUPAC Commission on the Nomenclature of Organic Chemistry, A Guide to IUPAC Nomenclature of Organic Compounds. ( Ltd., Oxford, UK: Blackwell Scientific Publications).
7. The Nanoscale Artificial NOSE.
8. (2000). Cyrano Sciences Unveils Portable Electronic Nose.
9. Di Natale C, Macagnano A, Martinelli E, Paolesse R, D'Arcangelo G, Roscioni C, Finazzi-Agro A and D'Amico A. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosensors&bioelectronics. 2003; 18:1209-1218.
10. Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B, Bianchi L, Rusca M and Mutti A. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respiratory research. 2005; 6:71.
11. Broza YY, Kremer R, Tisch U, Gevorkyan A, Shiban A, Best LA and Haick H. A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine: nanotechnology, biology, and medicine. 2013; 9:15-21.
12. Filipiak W, Filipiak A, Sponring A, Schmid T, Zelger B, Ager C, Klodzinska E, Denz H, Pizzini A, Lucciarini P, Jamnig H, Troppmair J and Amann A. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. Journal of breath research. 2014; 8:027111.
13. Wang Y, Hu Y, Wang D, Yu K, Wang L, Zou Y, Zhao C, Zhang X, Wang P and Ying K. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Cancer biomarkers: section A of Disease markers. 2012; 11:129-137.
14. Amal H, Leja M, Broza YY, Tisch U, Funka K, Liepniece-Karele I, Skapars R, Xu ZQ, Liu H and Haick H. Geographical variation in the exhaled volatile organic compounds. Journal of breath research. 2013; 7:047102.
15. Buszewski B, Ligor T, Jezierski T, Wenda-Piesik A, Walczak M and Rudnicka J. Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines. Analytical and bioanalytical chemistry. 2012; 404:141-146.
16. Hubers AJ, Brinkman P, Boksem RJ, Rhodius RJ, Witte BI, Zwinderman AH, Heideman DAM, Duin S, Koning R, Steenbergen RDM, Snijders PJF, Smit EF, Sterk PJ and Thunnissen E. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis. Journal of Clinical Pathology. 2014; 67:707-711.
17. Xu H, Wei Y, Zhu L, Huang J, Li Y, Liu F, Wang S and Liu S. Bifunctional magnetic nanoparticles for analysis of aldehyde metabolites in exhaled breath of lung cancer patients. Journal of Chromatography A. 2014; 1324:29-35.
18. Amal H, Leja M, Funka K, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I and Haick H. Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut. 2015.
19. Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Greenberg J, Kloss R, Maxfield RA, Munawar MI, Pass HI, Rashid A, Rom WN and Schmitt P. Prediction of lung cancer using volatile biomarkers in breath. Cancer biomarkers: section A of Disease markers. 2007; 3:95-109.
20. Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Kloss R, Maxfield RA, Munawar MI, Pass HI, Rashid A, Rom WN, Schmitt P and Wai J. Detection of lung cancer using weighted digital analysis of breath biomarkers. Clinica chimica acta; international journal of clinical chemistry. 2008; 393:76-84.
21. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC cancer. 2009; 9:348.
22. Ligor M, Ligor T, Bajtarevic A, Ager C, Pienz M, Klieber M, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Buszewski B, Miekisch W, Schubert J, et al. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clinical chemistry and laboratory medicine: CCLM / FESCC. 2009; 47:550-560.
23. Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Tietje O and Wong C. Prediction of breast cancer using volatile biomarkers in the breath. Breast cancer research and treatment. 2006; 99:19-21.
24. Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Rahbari-Oskoui F and Wong C. Volatile markers of breast cancer in the breath. The breast journal. 2003; 9:184-191.
25. de Gennaro G, Dragonieri S, Longobardi F, Musti M, Stallone G, Trizio L and Tutino M. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure. Analytical and bioanalytical chemistry. 2010; 398:3043-3050.
26. Dragonieri S, van der Schee MP, Massaro T, Schiavulli N, Brinkman P, Pinca A, Carratu P, Spanevello A, Resta O, Musti M and Sterk PJ. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls. Lung cancer (Amsterdam, Netherlands). 2012; 75:326-331.
27. Qin T, Liu H, Song Q, Song G, Wang HZ, Pan YY, Xiong FX, Gu KS, Sun GP and Chen ZD. The screening of volatile markers for hepatocellular carcinoma. Cancer epidemiology, biomarkers&prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010; 19:2247-2253.
28. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD and O'Neill HJ. Volatile organic compounds in exhaled air from patients with lung cancer. Clinical chemistry. 1985; 31:1278-1282.
29. Song G, Qin T, Liu H, Xu GB, Pan YY, Xiong FX, Gu KS, Sun GP and Chen ZD. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung cancer (Amsterdam, Netherlands). 2010; 67:227-231.
30. Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P and Wai J. Volatile biomarkers in the breath of women with breast cancer. Journal of breath research. 2010; 4:026003.
31. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S and Baumbach JI. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax. 2009; 64:744-748.
32. Rudnicka J, Walczak M, Kowalkowski T, Jezierski T and Buszewski B. Determination of volatile organic compounds as potential markers of lung cancer by gas chromatography-mass spectrometry versus trained dogs. Sensors and Actuators B-Chemical. 2014; 202:615-621.
33. Peled N, Hakim M, Bunn PA, Jr., Miller YE, Kennedy TC, Mattei J, Mitchell JD, Hirsch FR and Haick H. Non-invasive breath analysis of pulmonary nodules. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2012; 7:1528-1533.
34. Hakim M, Billan S, Tisch U, Peng G, Dvrokind I, Marom O, Abdah-Bortnyak R, Kuten A and Haick H. Diagnosis of head-and-neck cancer from exhaled breath. British journal of cancer. 2011; 104:1649-1655.
35. Wehinger A, Schmid A, Mechtcheriakov S, Ledochowski M, Grabmer C, Gastl GA and Amann A. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas. International Journal of Mass Spectrometry. 2007; 265:49-59.
36. Fu XA, Li M, Knipp RJ, Nantz MH and Bousamra M. Noninvasive detection of lung cancer using exhaled breath. Cancer medicine. 2014; 3:174-181.
37. Bousamra M, 2nd, Schumer E, Li M, Knipp RJ, Nantz MH, van Berkel V and Fu XA. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease. The Journal of thoracic and cardiovascular surgery. 2014; 148:1074-1080; discussion 1080-1071.
38. Phillips M, Beatty JD, Cataneo RN, Huston J, Kaplan PD, Lalisang RI, Lambin P, Lobbes MB, Mundada M, Pappas N and Patel U. Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms. PloS one. 2014; 9:e90226.
39. Chapman EA, Thomas PS, Stone E, Lewis C and Yates DH. A breath test for malignant mesothelioma using an electronic nose. The European respiratory journal. 2012; 40:448-454.
40. Xu ZQ, Broza YY, Ionsecu R, Tisch U, Ding L, Liu H, Song Q, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD, Leja M and Haick H. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. British journal of cancer. 2013; 108:941-950.
41. Zou Y, Zhang X, Chen X, Hu Y, Ying K and Wang P. Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease. Cancer biomarkers: section A of Disease markers. 2014; 14:371-379.
42. Pauling L, Robinson AB, Teranishi R and Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proceedings of the National Academy of Sciences of the United States of America. 1971; 68:2374-2376.
43. O'Neill HJ, Gordon SM, O'Neill MH, Gibbons RD and Szidon JP. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clinical chemistry. 1988; 34:1613-1618.
44. Preti G, Labows JN, Kostelc JG, Aldinger S and Daniele R. Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. Journal of chromatography. 1988; 432:1-11.
45. Broza YY and Haick H. Nanomaterial-based sensors for detection of disease by volatile organic compounds. Nanomedicine: nanotechnology, biology, and medicine. 2013; 8:785-806.
46. Konvalina G and Haick H. Sensors for breath testing: from nanomaterials to comprehensive disease detection. Accounts of chemical research. 2014; 47:66-76.
47. Tisch U and Haick H. Nanomaterials for cross-reactive sensor arrays. Mrs Bull. 2010; 35:797-803.
48. Buck L and Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell. 1991; 65:175-187.
49. Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, Tisch U and Haick H. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. British journal of cancer. 2010; 103:542-551.
50. Mochalski P, King J, Unterkofler K and Amann A. Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. The Analyst. 2013; 138:1405-1418.
51. Beauchamp J, Herbig J, Gutmann R and Hansel A. On the use of Tedlar (R) bags for breath-gas sampling and analysis. Journal of breath research. 2008; 2.
52. Mochalski P, Wzorek B, Sliwka I and Amann A. Suitability of different polymer bags for storage of volatile sulphur compounds relevant to breath analysis. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2009; 877:189-196.
53. Poli D, Goldoni M, Corradi M, Acampa O, Carbognani P, Internullo E, Casalini A and Mutti A. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2010; 878:2643-2651.
54. Amann A, Miekisch W, Pleil JD, Risby TH and Schubert J. (2010). Methodological issues of sample collection and analysis of exhaled breath. (Leeds, Uk: Maney Publishing).
55. Miekisch W, Kischkel S, Sawacki A, Liebau T, Mieth M and Schubert JK. Impact of sampling procedures on the results of breath analysis. Journal of breath research. 2008; 2:026007.
56. McGarvey LJ and Shorten CV. The effects of adsorption on the reusability of Tedlar air sampling bags. AIHAJ: a journal for the science of occupational and environmental health and safety. 2000; 61:375-380.
57. Miekisch W, Schubert JK and Noeldge-Schomburg GF. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clinica chimica acta; international journal of clinical chemistry. 2004; 347:25-39.
58. van den Velde S, Quirynen M, van Hee P and van Steenberghe D. Differences between alveolar air and mouth air. Analytical chemistry. 2007; 79:3425-3429.
59. Schubert JK, Spittler KH, Braun G, Geiger K and Guttmann J. CO(2)-controlled sampling of alveolar gas in mechanically ventilated patients. J Appl Physiol (1985). 2001; 90:486-492.
60. Kneepkens CMF, Lepage G and Roy CC. The Potential of the Hydrocarbon Breath Test as a Measure of Lipid-Peroxidation. Free Radical Bio Med. 1994; 17:127-160.
61. Risby TH and Solga SF. Current status of clinical breath analysis. Appl Phys B-Lasers O. 2006; 85:421-426.
62. Hauschild AC, Baumbach JI and Baumbach J. Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification. Genetics and molecular research: GMR. 2012; 11:2733-2744.
63. Kushch I, Arendacka B, Stolc S, Mochalski P, Filipiak W, Schwarz K, Schwentner L, Schmid A, Dzien A, Lechleitner M, Witkovsky V, Miekisch W, Schubert J, Unterkofler K and Amann A. Breath isoprene - aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study. Clinical Chemistry and Laboratory Medicine. 2008; 46:1011-1018.
64. Lechner M, Moser B, Niederseer D, Karlseder A, Holzknecht B, Fuchs M, Colvin S, Tilg H and Rieder J. Gender and age specific differences in exhaled isoprene levels. Respiratory Physiology&Neurobiology. 2006; 154:478-483.
65. Fuchs P, Loeseken C, Schubert JK and Miekisch W. Breath gas aldehydes as biomarkers of lung cancer. International journal of cancer Journal international du cancer. 2010; 126:2663-2670.
66. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, Greenberg J, Maxfield RA and Rom WN. Detection of lung cancer with volatile markers in the breath. Chest. 2003; 123:2115-2123.
67. Ebeler SE, Clifford AJ and Shibamoto T. Quantitative analysis by gas chromatography of volatile carbonyl compounds in expired air from mice and human. Journal of chromatography B, Biomedical sciences and applications. 1997; 702:211-215.
68. Spanel P, Smith D, Holland TA, Al Singary W and Elder JB. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid Communications in Mass Spectrometry. 1999; 13:1354-1359.
69. Szulejko JE, McCulloch M, Jackson J, McKee DL, Walker JC and Solouki T. Evidence for Cancer Biomarkers in Exhaled Breath. Ieee Sensors Journal. 2010; 10:185-210.
70. Queralto N, Berliner AN, Goldsmith B, Martino R, Rhodes P and Lim SH. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors. Journal of breath research. 2014; 8:027112.
71. Wilson AD and Baietto M. Advances in electronic-nose technologies developed for biomedical applications. Sensors (Basel, Switzerland). 2011; 11:1105-1176.
72. Wilson AD. Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath. Metabolites. 2015; 5:140-163.
73. Adiguzel Y and Kulah H. Breath sensors for lung cancer diagnosis. Biosensors&bioelectronics. 2015; 65:121-138.
74. Chen X, Cao MF, Li Y, Hu WJ, Wang P, Ying KJ and Pan HM. A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method. Measurement Science&Technology. 2005; 16:1535-1546.
75. Machado RF, Laskowski D, Deffenderfer O, Burch T, Zheng S, Mazzone PJ, Mekhail T, Jennings C, Stoller JK, Pyle J, Duncan J, Dweik RA and Erzurum SC. Detection of lung cancer by sensor array analyses of exhaled breath. American journal of respiratory and critical care medicine. 2005; 171:1286-1291.
76. Mazzone PJ, Hammel J, Dweik R, Na J, Czich C, Laskowski D and Mekhail T. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax. 2007; 62:565-568.
77. Dragonieri S, Annema JT, Schot R, van der Schee MP, Spanevello A, Carratu P, Resta O, Rabe KF and Sterk PJ. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung cancer (Amsterdam, Netherlands). 2009; 64:166-170.
78. D'Amico A, Pennazza G, Santonico M, Martinelli E, Roscioni C, Galluccio G, Paolesse R and Di Natale C. An investigation on electronic nose diagnosis of lung cancer. Lung cancer (Amsterdam, Netherlands). 2010; 68:170-176.
79. Shuster G, Gallimidi Z, Reiss AH, Dovgolevsky E, Billan S, Abdah-Bortnyak R, Kuten A, Engel A, Shiban A, Tisch U and Haick H. Classification of breast cancer precursors through exhaled breath. Breast cancer research and treatment. 2011; 126:791-796.
80. Yu K, Wang Y, Yu J and Wang P. A Portable Electronic Nose Intended for Home Healthcare Based on a Mixed Sensor Array and Multiple Desorption Methods. Sensor Letters. 2011; 9:876-883.
81. Mazzone PJ, Wang XF, Xu Y, Mekhail T, Beukemann MC, Na J, Kemling JW, Suslick KS and Sasidhar M. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2012; 7:137-142.
82. Santonico M, Lucantoni G, Pennazza G, Capuano R, Galluccio G, Roscioni C, La Delfa G, Consoli D, Martinelli E, Paolesse R, Di Natale C and D'Amico A. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling. Lung cancer (Amsterdam, Netherlands). 2012; 77:46-50.
83. Wang D, Yu K, Wang Y, Hu Y, Zhao C, Wang L, Ying K and Wang P. A Hybrid Electronic Noses' System Based on Mos-Saw Detection Units Intended for Lung Cancer Diagnosis. Journal of Innovative Optical Health Sciences. 2012; 5.
84. Leunis N, Boumans ML, Kremer B, Din S, Stobberingh E, Kessels AG and Kross KW. Application of an electronic nose in the diagnosis of head and neck cancer. The Laryngoscope. 2014; 124:1377-1381.
85. McWilliams A, Beigi P, Srinidhi A, Lam S and MacAulay C. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers using an Electronic Nose. IEEE transactions on bio-medical engineering. 2015.
86. Shehada N, Bronstrup G, Funka K, Christiansen S, Leja M and Haick H. Ultrasensitive Silicon Nanowire for Real-World Gas Sensing: Noninvasive Diagnosis of Cancer from Breath Volatolome. Nano letters. 2015; 15:1288-1295.
87. Gruber M, Tisch U, Jeries R, Amal H, Hakim M, Ronen O, Marshak T, Zimmerman D, Israel O, Amiga E, Doweck I and Haick H. Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study. British journal of cancer. 2014; 111:790-798.
88. Amal H, Shi DY, Ionescu R, Zhang W, Hua QL, Pan YY, Tao L, Liu H and Haick H. Assessment of ovarian cancer conditions from exhaled breath. International journal of cancer Journal international du cancer. 2015; 136:E614-622.
89. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L and McVay WP. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet. 1999; 353:1930-1933.
90. Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A and Haick H. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nature nanotechnology. 2009; 4:669-673.
91. Kischkel S, Miekisch W, Sawacki A, Straker EM, Trefz P, Amann A and Schubert JK. Breath biomarkers for lung cancer detection and assessment of smoking related effects - confounding variables, influence of normalization and statistical algorithms. Clinica Chimica Acta. 2010; 411:1637-1644.
92. Patterson SG, Bayer CW, Hendry RJ, Sellers N, Lee KS, Vidakovic B, Mizaikoff B and Gabram-Mendola SG. Breath analysis by mass spectrometry: a new tool for breast cancer detection? The American surgeon. 2011; 77:747-751.
93. Rudnicka J, Kowalkowski T, Ligor T and Buszewski B. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2011; 879:3360-3366.
94. Ulanowska A, Kowalkowski T, Trawinska E and Buszewski B. The application of statistical methods using VOCs to identify patients with lung cancer. Journal of breath research. 2011; 5:046008.
95. Mangler M, Freitag C, Lanowska M, Staeck O, Schneider A and Speiser D. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Ginekologia polska. 2012; 83:730-736.
96. Altomare DF, Di Lena M, Porcelli F, Trizio L, Travaglio E, Tutino M, Dragonieri S, Memeo V and de Gennaro G. Exhaled volatile organic compounds identify patients with colorectal cancer. The British journal of surgery. 2013; 100:144-150.
97. Garcia RA, Morales V, Martin S, Vilches E and Toledano A. Volatile Organic Compounds Analysis in Breath Air in Healthy Volunteers and Patients Suffering Epidermoid Laryngeal Carcinomas. Chromatographia. 2014; 77:501-509.
98. Li J, Peng Y, Liu Y, Li W, Jin Y, Tang Z and Duan Y. Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry. Clinica chimica acta; international journal of clinical chemistry. 2014; 436:59-67.
99. Wang C, Sun B, Guo L, Wang X, Ke C, Liu S, Zhao W, Luo S, Guo Z, Zhang Y, Xu G and Li E. Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibroma. Scientific reports. 2014; 4:5383.
100. Wang C, Ke C, Wang X, Chi C, Guo L, Luo S, Guo Z, Xu G, Zhang F and Li E. Noninvasive detection of colorectal cancer by analysis of exhaled breath. Analytical and bioanalytical chemistry. 2014; 406:4757-4763.
101. Guo L, Wang C, Chi C, Wang X, Liu S, Zhao W, Ke C, Xu G and Li E. Exhaled breath volatile biomarker analysis for thyroid cancer. Translational research: the journal of laboratory and clinical medicine. 2015.
102. Hietanen E, Bartsch H, Bereziat JC, Camus AM, McClinton S, Eremin O, Davidson L and Boyle P. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. European journal of clinical nutrition. 1994; 48:575-586.
103. Rieder J, Lirk P, Ebenbichler C, Gruber G, Prazeller P, Lindinger W and Amann A. Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening. Wiener klinische Wochenschrift. 2001; 113:181-185.
104. Steeghs MM, Cristescu SM, Munnik P, Zanen P and Harren FJ. An off-line breath sampling and analysis method suitable for large screening studies. Physiological measurement. 2007; 28:503-514.
105. Handa H, Usuba A, Maddula S, Baumbach JI, Mineshita M and Miyazawa T. Exhaled breath analysis for lung cancer detection using ion mobility spectrometry. PloS one. 2014; 9:e114555.
106. Ma H, Li X, Chen J, Wang H, Cheng T, Chen K and Xu S. Analysis of human breath samples of lung cancer patients and healthy controls with solid-phase microextraction (SPME) and flow-modulated comprehensive two-dimensional gas chromatography (GC x GC). Analytical Methods. 2014; 6:6841-6849.
107. Kumar S, Huang J, Abbassi-Ghadi N, Mackenzie HA, Veselkov KA, Hoare JM, Lovat LB, Spanel P, Smith D and Hanna GB. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma. Annals of surgery. 2015.
108. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Analytical biochemistry. 1997; 247:272-278.